UroLift vs. Rezum: Comparing Minimally Invasive BPH Treatments to Find Your Best Option

If you've been diagnosed with BPH and medications aren't giving you the relief you need, you're probably weighing your surgical options—and trying to figure out which one won't upend your life.

You're not alone. Benign prostatic hyperplasia affects roughly 50% of men by age 60, and that number climbs to 90% by age 85. For decades, men facing this decision had limited choices: keep taking pills that didn't fully work, or undergo traditional surgery like TURP with its lengthy recovery and high risk of sexual side effects.

That's changed. UroLift and Rezum have emerged as the two leading minimally invasive surgical therapies for BPH, offering real symptom relief without the trade-offs that made older procedures so unappealing.

This article breaks down how each procedure works, who it's best suited for, what recovery actually looks like, and how their long-term results compare. By the end, you'll have a clearer picture of which option might fit your anatomy, your symptoms, and your life.

What Is BPH and Why Are Minimally Invasive Treatments Gaining Popularity?

Benign prostatic hyperplasia is a non-cancerous enlargement of the prostate gland. As the prostate grows, it compresses the urethra—the tube that carries urine out of the body—and creates the symptoms most men know too well: weak stream, frequent trips to the bathroom, waking up multiple times at night to urinate, and the feeling that your bladder never fully empties.

BPH won't kill you, but it will wear you down. Sleep suffers. Travel becomes a calculation of restroom locations. Quality of life erodes in ways that are hard to explain to anyone who hasn't experienced it.

Why Medication Isn't Always Enough

Alpha-blockers and 5-alpha reductase inhibitors can reduce symptoms, but they don't fix the underlying structural problem—an enlarged prostate physically blocking urine flow. These medications also come with their own issues: dizziness, fatigue, and sexual side effects that make some men stop taking them altogether.

Traditional surgery like TURP or HoLEP is effective at removing obstructing tissue, but the trade-offs are significant. Retrograde ejaculation occurs in 75–100% of TURP patients, and recovery can take weeks. According to the American Urological Association BPH treatment guidelines, minimally invasive surgical therapies now offer a middle path—procedures that can be done in an office or outpatient setting, preserve sexual function, and get men back to normal activities within days rather than weeks.

That's why UroLift and Rezum have become the two most talked-about options for men who need more than medication but want to avoid traditional surgery.

How UroLift Works

The UroLift system uses small permanent implants to mechanically lift and hold enlarged prostate tissue away from the urethra. Think of it like tiebacks on a curtain—the implants pin the obstructing lobes to the side, opening up the channel so urine can flow freely.

There's no cutting, heating, or removal of tissue. A urologist inserts a small delivery device through the urethra, places the implants (typically 4–6), and the procedure is done. Most UroLift procedures take about 20–30 minutes and are performed in an office or outpatient setting under local anesthesia.

What Recovery Looks Like

Because the implants physically reposition tissue rather than destroying it, results are nearly immediate. Most men notice symptom improvement within two weeks. There's typically no catheter required after the procedure—or if one is placed, it's removed the same day.

The UroLift System official site provides detailed information on the device and procedure for patients who want to dig deeper into the specifics.

The Clinical Evidence

UroLift received FDA clearance in 2013, and five-year follow-up data shows durable symptom improvement for most patients. What sets it apart from other BPH treatments is the sexual function data: UroLift is the only leading BPH procedure shown to not cause new, sustained erectile or ejaculatory dysfunction in clinical trials.

The CLEAR trial, published in 2024, directly compared UroLift to Rezum and found that UroLift patients reported a superior early experience at the three-month mark—faster symptom relief and quicker return to normal activities.

How Rezum Works

Rezum takes a different approach. Instead of repositioning tissue, it destroys it using convective water vapor—steam delivered directly into the enlarged prostate.

During the procedure, a urologist inserts a small device through the urethra and delivers controlled steam injections into targeted areas of the prostate. Each injection lasts about nine seconds, and most patients receive between 2–7 injections depending on prostate size and shape. The procedure takes approximately 30–60 minutes and is performed in an office or outpatient setting, typically under local anesthesia or light sedation.

How It Relieves Symptoms

The steam destroys the targeted prostate cells on contact. Over the following weeks, the body naturally absorbs the dead tissue and the prostate shrinks, reducing pressure on the urethra.

This process takes time. Unlike UroLift's near-immediate results, Rezum patients typically notice improvement within 2–6 weeks, with the full benefit arriving around the three-month mark. A catheter is usually required for 3–7 days after the procedure while initial swelling subsides.

The Rezum Water Vapor Therapy official site offers additional details on the procedure and what patients can expect.

The Clinical Evidence

Rezum received FDA clearance in 2015. Five-year data from the pivotal trial shows a surgical retreatment rate of just 4.4%—meaning fewer than 1 in 20 patients needed another procedure within five years.

One key anatomical advantage: Rezum can treat prostates with an obstructing middle lobe, a common configuration that isn't ideal for UroLift. The procedure also preserves sexual function, with no reported new-onset erectile dysfunction in clinical studies. Approximately 2% of patients report decreased semen volume.

UroLift vs. Rezum: head-to-head comparison

Both procedures work. Both preserve sexual function. Both can be done in an office setting without general anesthesia. But they work differently, recover differently, and may suit different patients.

How they work: UroLift uses small mechanical implants to physically lift and pin back the prostate tissue that's pressing into the urethra. Rezum takes a different approach, injecting steam into the obstructing tissue to ablate and destroy it. Over the following weeks, the body reabsorbs the treated tissue and the channel widens naturally.

Procedure time and anesthesia: UroLift runs about 20 to 30 minutes. Rezum takes slightly longer at 30 to 60 minutes. Both use local anesthesia or light sedation.

Catheter use and recovery: This is one of the bigger practical differences. UroLift usually doesn't require a catheter, or if one is placed, it's removed the same day. Rezum typically requires a catheter for 3 to 7 days while the treated tissue swells before it starts to shrink. That catheter requirement extends Rezum's early recovery. Most UroLift patients return to normal activities within days. Rezum patients generally need 1 to 2 weeks.

Time to symptom relief: UroLift delivers noticeable improvement within 1 to 2 weeks. Rezum works more gradually, with improvement building over 2 to 6 weeks and full effect arriving around the 3-month mark.

Sexual function: Both procedures preserve sexual function with no new-onset erectile dysfunction. UroLift shows no ejaculatory dysfunction in clinical data. Rezum reports roughly 2% of patients noticing decreased semen volume, but overall ejaculatory function remains intact.

Prostate size and anatomy: Both treat prostates in the 30 to 80 cc range. UroLift works best for lateral lobe obstruction, where tissue is squeezing in from the sides. Rezum has an advantage for men with middle lobe enlargement, since the steam can reach tissue that UroLift's implants can't effectively address.

Long-term durability: This is where Rezum pulls ahead. Five-year retreatment rates for UroLift fall between 10.7 and 13.6%, meaning roughly 1 in 8 to 1 in 10 patients need a follow-up procedure. Rezum's retreatment rate is lower at 4.4 to 6.8%, likely because destroying tissue outright produces a more permanent result than mechanically holding it in place.

Bottom line: UroLift is the better fit for men who want the fastest possible recovery and near-immediate relief. Rezum suits men who are willing to trade a slightly longer recovery for potentially more durable tissue reduction.

What the Numbers Tell Us

UroLift gets you back to life faster. Most men return to normal activities within a few days, and symptom improvement comes within one to two weeks. If minimizing downtime is your priority, that speed matters.

Rezum appears to offer stronger durability over time. A 2025 multicenter analysis by Lim et al. confirmed lower retreatment rates for Rezum at the five-year mark. Because the tissue is actually destroyed and reabsorbed rather than repositioned, there's less chance of the prostate re-obstructing over time. A peer-reviewed comparison of UroLift and Rezum outcomes found similar efficacy between the two at three years, but the durability gap widens slightly with longer follow-up.

Anatomy Is the Deciding Factor for Some Men

Your prostate's shape matters as much as its size. UroLift works best when the obstruction comes from the lateral lobes—the sides of the prostate. If you have a significant middle lobe pushing up into the bladder, Rezum is often the better choice because it can target that tissue directly.

Both procedures preserve sexual function, which is the main reason men choose either one over traditional TURP. But UroLift has the edge in ejaculatory preservation data—no new-onset ejaculatory dysfunction in trials, compared to the small percentage of Rezum patients who notice reduced semen volume.

Side Effects and Recovery — What to Expect

Both procedures cause temporary urinary symptoms during recovery. The difference is how long those symptoms last and what the recovery period demands from you.

UroLift Recovery

Most men experience mild blood in the urine, urinary discomfort, and urgency for the first few days after UroLift. These symptoms typically resolve within a week.

The biggest practical advantage: no catheter in most cases. When a catheter is placed, it's usually removed the same day. Most men return to normal activities within two to three days. Some resume light work the next day.

Serious complications are uncommon. A small percentage of patients experience urinary retention or blood clots requiring intervention, but these are rare.

Rezum Recovery

Rezum's recovery takes longer because the body needs time to absorb the destroyed tissue. Urgency, frequency, and discomfort during urination are common for two to four weeks after the procedure. Mild blood in the urine can persist during this period.

A catheter is typically worn for three to seven days post-procedure—a significant difference from UroLift's same-day removal. About 23% of patients experience temporary urinary retention requiring catheter replacement, making this the most commonly reported complication.

Full symptom improvement can take up to three months as the prostate tissue gradually shrinks. Plan for one to two weeks before returning to normal activities.

Comparing the Two

The side effects themselves are similar in type—urinary discomfort, urgency, some blood in the urine. The difference is duration. UroLift patients are generally back to baseline comfort within a week. Rezum patients should expect a longer adjustment period, with symptoms tapering gradually over several weeks.

If wearing a catheter for several days or taking two weeks off from regular activities isn't feasible for you, that's worth factoring into your decision.

Cost and Insurance Considerations

Both UroLift and Rezum are covered by most major insurance plans, including Medicare. Out-of-pocket costs vary based on your insurance, the facility where the procedure is performed, and your geographic location.

UroLift may carry a slightly higher upfront cost due to the permanent implants themselves. Rezum's equipment costs are generally lower, though procedure fees vary by practice.

However, upfront cost isn't the whole picture. Rezum's lower retreatment rate could translate to fewer long-term expenses for some patients. If you're comparing costs, factor in the possibility of needing a second procedure down the road—something that happens in roughly 10–14% of UroLift patients versus 4–7% of Rezum patients within five years.

Before scheduling, ask your urologist's office to verify your insurance coverage and provide a cost estimate specific to your plan. Most offices handle this routinely and can tell you what to expect.

One note: cost should inform your decision, not drive it. The best procedure is the one that matches your anatomy, your symptoms, and your life—not necessarily the one with the lowest copay.

How to Know Which Procedure Is Right for You

There's no universal answer to the UroLift vs. Rezum question. The right choice depends on your specific anatomy, how quickly you need relief, and what trade-offs you're willing to accept.

Factors That Influence the Decision

Prostate anatomy. If imaging or cystoscopy shows a significant middle lobe, Rezum is often the better fit. UroLift works best for lateral lobe obstruction and isn't designed to address tissue pushing up from the middle.

How fast you need relief. UroLift delivers noticeable improvement within one to two weeks. Rezum's benefits emerge gradually over two to three months. If you're planning around a specific event or simply can't tolerate weeks of waiting, that timeline matters.

Tolerance for recovery. UroLift typically means no catheter and a return to normal activities within days. Rezum usually requires a catheter for several days and a longer adjustment period. Be honest with yourself about what you can manage.

Long-term durability. If minimizing the chance of needing a second procedure is your priority, Rezum's lower five-year retreatment rate may tip the balance. The tissue is destroyed rather than repositioned, which appears to produce more lasting results for some men.

Sexual function concerns. Both procedures preserve erectile function. UroLift has the strongest clinical data on ejaculatory preservation—no new-onset dysfunction in trials. Rezum preserves function for most men, though a small percentage notice reduced semen volume.

The Evaluation Process

Your urologist will typically perform a cystoscopy—a quick camera exam—to visualize your prostate's size and shape. This is how they determine whether you have a middle lobe and how the obstruction is configured. Some practices also use urodynamic testing to measure how well your bladder empties.

You'll review your symptom severity using a standardized questionnaire like the AUA Symptom Score, which helps quantify how much BPH is affecting your daily life.

The best outcomes come from shared decision-making. A urologist who performs both UroLift and Rezum can walk you through the options based on your specific anatomy and priorities—not just steer you toward the procedure they happen to prefer.

UroLift vs Rezum

UroLift and Rezum both deliver what men with BPH want most: symptom relief without the sexual side effects and lengthy recovery of traditional surgery. Neither procedure is universally better. The right choice comes down to your prostate's anatomy, how quickly you need results, and whether minimizing retreatment risk matters more to you than minimizing downtime.

UroLift offers speed—faster recovery, faster symptom relief, no catheter for most patients. Rezum offers durability—tissue destruction rather than repositioning, with lower retreatment rates at five years.

Both preserve sexual function. Both can be performed in an office setting. Both represent a significant step forward from the days when TURP was the only surgical option.

What you shouldn't do is wait indefinitely. Untreated BPH doesn't just cause inconvenience. Over time, it can lead to urinary retention, recurrent infections, bladder stones, and permanent bladder damage. The earlier you address it, the more options you have.

If you're considering a minimally invasive BPH treatment, the next step is an evaluation with a urologist who can assess your anatomy and discuss both procedures based on your situation—not a one-size-fits-all recommendation. Find a BPH specialist near you to schedule a consultation and get a personalized assessment.

Frequently Asked Questions

Is UroLift or Rezum better for BPH?

Neither is universally better. UroLift offers faster symptom relief and quicker recovery—most men are back to normal within days and notice improvement within two weeks. Rezum may provide more durable long-term results, with retreatment rates roughly half that of UroLift at five years. The best choice depends on your prostate size, anatomy (particularly whether you have a middle lobe), and whether you prioritize speed of recovery or long-term durability.

Does UroLift or Rezum affect sexual function?

Both procedures are designed to preserve sexual function, which is their primary advantage over traditional surgery like TURP. UroLift has the strongest clinical data, showing no new-onset erectile or ejaculatory dysfunction in trials. Rezum also preserves erectile function, though approximately 2% of men report decreased semen volume after the procedure.

How long do UroLift and Rezum results last?

UroLift has demonstrated durable symptom relief through five years of follow-up, with a retreatment rate of approximately 10–14%. Rezum's five-year data shows a retreatment rate of approximately 4–7%. Both procedures are significantly less invasive than undergoing a repeat TURP if symptoms return.

Can you get Rezum or UroLift if your prostate is very large?

Both procedures are FDA-cleared for prostates between 30 and 80 cubic centimeters. If your prostate is larger than 80 cc, your urologist may recommend a different approach such as HoLEP, Aquablation, or traditional TURP. A proper evaluation with imaging or cystoscopy will determine your prostate size and which procedures are appropriate for you.